Bayesian Capital Management, LP Neogenomics Inc Transaction History

Bayesian Capital Management, LP

  • $838 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$9.09 - $19.45 $36,360 - $77,800
4,000 Added 17.28%
27,143 $472,000
Q4 2022

Feb 14, 2023
BUY
$6.45 - $12.07 $59,340 - $111,044
9,200 Added 65.98%
23,143 $213,000
Q3 2022

Nov 14, 2022
BUY
$7.86 - $12.91 $109,591 - $180,004
13,943 New
13,943 $120,000

Others Institutions Holding NEO

# of Institutions
296
Shares Held
125M
Call Options Held
698K
Put Options Held
116K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.7B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email